Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163


Trypanosoma cruzi uses macropinocytosis as an additional entry pathway into mammalian host cell.

Barrias ES, Reignault LC, De Souza W, Carvalho TM.

Microbes Infect. 2012 Nov;14(14):1340-51. doi: 10.1016/j.micinf.2012.08.003. Epub 2012 Sep 23.


Dynasore, a dynamin inhibitor, inhibits Trypanosoma cruzi entry into peritoneal macrophages.

Barrias ES, Reignault LC, De Souza W, Carvalho TM.

PLoS One. 2010 Jan 20;5(1):e7764. doi: 10.1371/journal.pone.0007764.


Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway.

Delpeut S, Sisson G, Black KM, Richardson CD.

J Virol. 2017 Apr 28;91(10). pii: e02191-16. doi: 10.1128/JVI.02191-16. Print 2017 May 15.


Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation.

Woolsey AM, Sunwoo L, Petersen CA, Brachmann SM, Cantley LC, Burleigh BA.

J Cell Sci. 2003 Sep 1;116(Pt 17):3611-22. Epub 2003 Jul 22.


Structures containing galectin-3 are recruited to the parasitophorous vacuole containing Trypanosoma cruzi in mouse peritoneal macrophages.

Reignault LC, Barrias ES, Soares Medeiros LC, de Souza W, de Carvalho TM.

Parasitol Res. 2014 Jun;113(6):2323-33. doi: 10.1007/s00436-014-3887-8. Epub 2014 Apr 24.


Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells.

Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Chandran B.

J Virol. 2009 May;83(10):4895-911. doi: 10.1128/JVI.02498-08. Epub 2009 Mar 11.


Macropinocytosis is the entry mechanism of amphotropic murine leukemia virus.

Rasmussen I, Vilhardt F.

J Virol. 2015 Feb;89(3):1851-66. doi: 10.1128/JVI.02343-14. Epub 2014 Nov 26.


Trypanosoma cruzi Needs a Signal Provided by Reactive Oxygen Species to Infect Macrophages.

Goes GR, Rocha PS, Diniz AR, Aguiar PH, Machado CR, Vieira LQ.

PLoS Negl Trop Dis. 2016 Apr 1;10(4):e0004555. doi: 10.1371/journal.pntd.0004555. eCollection 2016 Apr.


Trypanosoma cruzi: Entry into Mammalian Host Cells and Parasitophorous Vacuole Formation.

Barrias ES, de Carvalho TM, De Souza W.

Front Immunol. 2013 Aug 1;4:186. doi: 10.3389/fimmu.2013.00186. eCollection 2013.


Trypanosoma cruzi: mechanisms for entry into host cells.

Hall BF.

Semin Cell Biol. 1993 Oct;4(5):323-33. Review.


Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes.

Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA.

PLoS Pathog. 2010 Sep 16;6(9):e1001110. doi: 10.1371/journal.ppat.1001110.


The marsupial trypanosome Trypanosoma copemani is not an obligate intracellular parasite, although it adversely affects cell health.

Cooper C, Andrew Thompson RC, Rigby P, Buckley A, Peacock C, Clode PL.

Parasit Vectors. 2018 Sep 20;11(1):521. doi: 10.1186/s13071-018-3092-1.


Trypanosoma cruzi recognition by macrophages and muscle cells: perspectives after a 15-year study.

De Araujo-Jorge TC, Barbosa HS, Meirelles MN.

Mem Inst Oswaldo Cruz. 1992;87 Suppl 5:43-56. Review.


Mechanisms of host cell invasion by Trypanosoma cruzi.

Caradonna KL, Burleigh BA.

Adv Parasitol. 2011;76:33-61. doi: 10.1016/B978-0-12-385895-5.00002-5. Review.


Neurotrophin receptor TrkC is an entry receptor for Trypanosoma cruzi in neural, glial, and epithelial cells.

Weinkauf C, Salvador R, Pereiraperrin M.

Infect Immun. 2011 Oct;79(10):4081-7. doi: 10.1128/IAI.05403-11. Epub 2011 Jul 25.


Molecular and cellular mechanisms involved in the Trypanosoma cruzi/host cell interplay.

Romano PS, Cueto JA, Casassa AF, Vanrell MC, Gottlieb RA, Colombo MI.

IUBMB Life. 2012 May;64(5):387-96. doi: 10.1002/iub.1019. Epub 2012 Mar 27. Review.


Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.

Campos MA, Closel M, Valente EP, Cardoso JE, Akira S, Alvarez-Leite JI, Ropert C, Gazzinelli RT.

J Immunol. 2004 Feb 1;172(3):1711-8.

Supplemental Content

Support Center